FDA Investigator James L Dunnie, Jr
James L Dunnie, Jr has conducted inspections on 39 sites in 13 countries as of 24 Apr 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
39
Last Inspection Date:
24 Apr 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
Canada,
Germany,
Italy,
Sweden,
India,
Spain,
Switzerland,
United Kingdom of Great Britain and Northern Ireland,
Denmark,
France,
Malta,
Romania,
United States of America
FDA Investigators that have inspected at least one site in common with James L Dunnie, Jr:
Ademola O Daramola,
Anastasia M Shields,
Andrea A Branche,
Anita Narula, PhD,
Ann L Demarco,
Ann Marie Montemurro,
Ann Marie Schofield,
Ariel Cruz Figueroa,
Arsen Karapetyan,
Arthur S Williams, Jr,
Ashley J Burns,
Azza Talaat,
Barbara Janine Breithaupt,
Barbara M Frazier,
Bo Chi, PhD,
Brian D Nicholson,
Bruce H Mccullough,
Carl A Huffman, III,
Carla J Lundi,
Carmen Y Fisher,
Caryn M Mcnab,
Cassandra L Abellard,
Charisse K Green,
Charles L Zhou,
Charles M Edwards,
Charles R Cote, RIC,
Chikako Torigoe, PhD,
Chris A Sack,
Christian D Lynch (CDL),
Christina Capacci Daniel, PhD,
Christopher T Middendorf,
Craig A Garmendia,
Cynthia Jim, CSO,
Daniel J Grabicki,
Daniel J Lahar,
Darren S Brown,
David J Gomes,
David J Hafner,
David M Beltran,
Debra I Love,
Dell S Moller,
Dennis Cantellops Paite,
Doan T Nguyen, PharmD,
Don H Bark, PhD,
Donald L Lech,
Dongping Dai, PhD,
Douglas A Campbell,
Dr. Barbara D Paul, PhD,
Dr. Carmelo Rosa,
Dr. Robert C Horan, MD,
Dr. Zhihao Qiu (Peter), PhD,
Edmund F Mrak, Jr,
Eliezar Ramos,
Emest F Bizjak,
Emilie E Kahn,
Erika V Butler,
Francis A Guidry,
Frank Wackes,
Frederick F Razzaghi,
George J Flynn,
George Pyramides,
Gerald B Seaborn, Jr,
Geraldine D Sanders,
German Rivera,
Ginger M Sykes,
Gloria E Parra,
Grace E Mcnally,
Guerlain Ulysse,
Gwyn G Dickinson,
Hamet M Toure, PharmD MPH,
Helen B Ricalde,
Holly Brevig,
Iram R Hassan, PhD,
Ivis L Negron,
Jacob G Lutz,
Jacqueline Mdiaz Albertini,
James C Maclaughlin,
James I Giefer,
James P Mcevoy,
Jeffrey A Sommers,
Jennifer Lalama,
Jennifer M Gogley,
Joan A Loreng,
Joanne E King,
Joey V Quitania,
John P Mistler,
Jose Acruz Gonzalez,
José E Meléndez,
Jose R Hernandez,
Junho Pak,
Justin A Boyd,
Justine Tomasso,
Karen E D'orazio,
Karen Takahashi,
Katherine Szestypalow,
Kathy E Noe,
Kellia N Hicks,
Kelvin Cheung,
Kenneth H Williams,
Kenneth Nieves,
Kevin D Kallander,
Kham Phommachanh,
Kimberley A Hoefen,
Kimberly Lewandowski Walker,
Kip J Hanks,
Ko U Min,
Kristen D Evans,
Kumar G Janoria,
Larry K Austin,
Latorie S Jones,
Laura S Huffman,
Lawrence Harmon, Jr,
LCDR Chad N Thompson,
LCDR Debra Emerson,
Liatte Kreuger, PharmD,
Linda Thai,
Lisa Hornback,
Lisa M Bellows,
Lucas B Leake,
Luis A Dasta,
Luis Mburgos Medero,
Lydia I Rosas Marty,
Marcus F Yambot,
Marie A Fadden,
Marie F Morin,
Mariza M Jafary,
Maryam Tabatabaie,
Massoud Motamed,
Matthew D Schnittker,
Matthew R Dionne,
Maya M Davis,
Meisha R Sampson,
Melissa D Ray,
Melissa J Garcia,
Meyer J Slobotsky,
Michael A Charles,
Michael E Maselli,
Michael R Goga,
Michael Shanks, MS,
Michele Gottshall,
Michele L Obert,
Michelle Yclark Stuart,
Miguel A Martinez Perez,
Mihaly S Ligmond,
Mikhail V Ovanesov, PhD,
Minh D Phan,
Mizanne E Lewis,
Mra B Kamberem,
Mra Davism,
Mra Greenc,
Mra M Barbosar,
Mra Mcculloughj,
Muralidhara B Gavini, PhD,
Nadeem I Chaudhry,
Nancy G Schmidt,
Neal L Adams,
Nebil A Oumer,
Nicholas A Violand,
Nicholas L Paulin,
Niketa Patel,
Omotunde O Osunsanmi,
Pankaj H Amin,
Paraluman S Leonin,
Parul M Patel,
Patricia F Hughes, PhD,
Patrick C Klotzbuecher,
Patrick L Wisor,
Patsy J Domingo,
Paul A Bonneau,
Paul E Stein,
Paul L Bellamy,
Paul L Figarole, Jr,
Paula A Trost,
Prabhu P Raju,
Rafael E Arroyo,
Rafael Nevarez Nieves,
Rafael Padilla,
Ralph H Vocque,
Ralph Jerndal,
Ramon E Martinez,
Raymond T Oji,
Reba A Gates,
Rebecca E Dombrowski,
Regina T Brown,
Reyes Candau Chacon, PhD,
Richard E Needham,
Richard K Vogel,
Richard L Friedman,
Robert C Coleman,
Robert C Steyert,
Robert D Tollefsen,
Robert J Doyle,
Robert J Martin,
Rodney D Combs,
Roger F Zabinski,
Rosanna M Goodrich,
Rose Ashley,
Roy R Rinc,
Russell J Glapion,
Russell K Riley,
Ruth Moore, PhD,
Saied A Asbagh,
Samantha J Bradley,
Samina S Khan,
Samuel K Gibbons, Jr,
Sangeeta M Khurana, PhD,
Santiago Gallardo Johnson,
Santos E Camara,
Satheesh Thomas,
Scott T Ballard,
Sean R Marcsisin,
Seneca D Toms,
Sergey S Akimov,
Sharon K Thoma, PharmD,
Shirley J Berryman,
Sidney B Priesmeyer,
Simone E Pitts,
Sixto M Mercado Rios,
Sneha S Patel,
Stephanie L Shapley,
Stephen C Smith,
Stephen D Brown,
Stephen D Eich,
Steven C Madzo,
Steven Frisbee,
Steven M Weinman,
Susan F Laska, MS,
Susan M Jackson,
Susan P Bruederle,
Susan T Hadman,
Susanne M Richardson, MS RAC,
Suzanne M Healy,
Suzanne M Muchene,
Tawny L Colling,
Temar Q Williams,
Theressa B Smith,
Thomas J Arista,
Thuy T Nguyen, LCDR,
Tina M Pawlowski,
Tonnie L Carter,
Torrance J Slayton,
Tracy K Li,
Truong Xuan Nguyen (Andy),
Unnee Ranjan,
Vilmary Negron Rodriguez,
Virginia Carroll, PhD,
Vlada Matusovsky,
Wayne E Seifert,
Wendy G Tan, PhD,
William A Warnick,
Xianghong Jing (Emily), PhD,
Xiaohui Shen,
Xiaokuang Lai, PhD,
Xiaoping Guan,
Yasamin Ameri,
Yehualashet A Gessesse,
Yumi J Hiramine,
Zachary A Bogorad,
Zhong Li, PhD,
Zonglin Hu
James L Dunnie, Jr's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| September, 2009 | FDA 483 | Arrow Pharm Limited - Form 483, 2009-09-17 |
| April, 2015 | FDA 483 | Torrent Pharmaceuticals Limited - Form 483, 2015-04-10 |
| October, 2001 | EIR | Takeda GmbH - EIR, 2001-10-17 |
| September, 2005 | EIR | Vetter Pharma Fertigung GmbH & Co. KG (Langenargen Eisenbahnstrasse) - EIR, 2005-09-22 |
| November, 2000 | FDA 483 | F. Hoffmann-La Roche AG - Form 483, 2000-11-10 |
| October, 2001 | FDA 483 | Takeda GmbH - Form 483, 2001-10-17 |
| November, 2006 | EIR | Farmhispania S.A. - EIR, 2006-11-09 |
| November, 2006 | FDA 483 | Farmhispania S.A. - Form 483, 2006-11-09 |
| October, 2001 | FDA 483 Response | Takeda GmbH - Form 483R, 2001-12-14 |
| November, 2015 | FDA 483 | AstraZeneca Dunkerque Production - Form 483, 2015-11-20 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more